BF Biosciences Limited (PSX:BFBIO)
135.00
-1.93 (-1.41%)
At close: May 12, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 12.1 billion as of May 12, 2026. Its market cap has decreased by -9.71% in one year.
Market Cap
12.10B
Enterprise Value
12.92B
Revenue
8.86B
Ranking
n/a
PE Ratio
20.44
Stock Price
135.00
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 12.10B, an increase of 63.28%. That is a compound annual growth rate of 37.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 12.10B | -2.55% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
| Oct 22, 2024 | 7.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Archroma Pakistan | 13.59B |
| The Thal Industries Corporation | 13.54B |
| Big Bird Foods | 13.45B |
| Hum Network | 13.27B |
| Macter International | 12.73B |
| MCB investment management | 12.71B |
| Zarea | 12.60B |
| Siemens (Pakistan) Engineering | 12.57B |